Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026)

Adaptin Bio has disclosed Other Non Operating Income across 3 years of filings, most recently posting $326345.0 for Q1 2026.

• Quarterly Other Non Operating Income rose 5270.23% year-over-year to $326345.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $659002.0 (up 2932.47% YoY) and the FY2025 annual result came in at $326345.0, up 2009.9% from the prior year.
• Other Non Operating Income slipped to $326345.0 in Q1 2026, from $332657.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $332657.0 in Q3 2025 and bottomed at -$8332.0 in Q4 2024.
• The 3-year median for Other Non Operating Income is -$2373.0 (2024), against an average of $90800.4.
• The widest YoY moves for Other Non Operating Income: up 5423.36% in 2025, down 4645.86% in 2025.
• Adaptin Bio's Other Non Operating Income stood at -$8332.0 in 2024, then soared by 4092.52% to $332657.0 in 2025, then dropped by 1.9% to $326345.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $326345.0, $332657.0, and -$6312.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.